Learn More
Medchemexpress LLC 2-chloro-6-benzylamino-9-methylpurine | 101622-53-1 | MFCD00467327 | 98.2% | 273.72 g·mol⁻1 | C13H12ClN5 | 25 MG

Supplier: Medchemexpress LLC HYW47810225MG
CDK2-IN-13 is a small-molecule inhibitor of cyclin-dependent kinase 2 (CDK2) used for research into cell cycle regulation and cancer biology. It is reported to have an IC50 of 12 μM. Chemical identifiers include CAS 101622-53-1, molecular formula C13H12ClN5, and molecular weight 273.72 g·mol⁻1. The compound is supplied in milligram quantities for laboratory research.
- CDK2 inhibition (IC50 12 μM) suitable for target validation studies.
- Supports cancer and cell cycle research applications.
- Well-characterized identity (CAS 101622-53-1; C13H12ClN5; MW 273.72).
- High reported purity for research use (98.2%).
- Available in small-mass packaging convenient for assay development.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.